Funding and Investments

Jun 07, 2018
By BioPharm International Editors
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
May 31, 2018
By BioPharm International Editors
Ingenza, in partnership with the University of Dundee and Drochaid Research Services, will work on a project to recycle CO2 emissions from bioprocessing plants to serve as feedstock and energy inputs.
May 25, 2018
By BioPharm International Editors
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
May 17, 2018
By BioPharm International Editors
Internationalization and regulatory reform are driving growth and investment China.
May 16, 2018
By BioPharm International Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
Apr 20, 2018
By BioPharm International Editors
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
Apr 12, 2018
By BioPharm International Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Feb 22, 2018
By BioPharm International Editors
The company aims to add the additional analytical services in the European Union throughout 2018.
Feb 12, 2018
By BioPharm International Editors
The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.
Feb 06, 2018
By BioPharm International Editors
Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.
native1_300x100
lorem ipsum